Christina R Klein, MD | |
413 Lilly Rd Ne, Olympia, WA 98506-5133 | |
(360) 486-6402 | |
Not Available |
Full Name | Christina R Klein |
---|---|
Gender | Female |
Speciality | Hospice/palliative Care |
Experience | 10 Years |
Location | 413 Lilly Rd Ne, Olympia, Washington |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1154731727 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2081H0002X | Physical Medicine & Rehabilitation - Hospice And Palliative Medicine | MD60971319 (Washington) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Providence St Peter Hospital | Olympia, WA | Hospital |
Providence Centralia Hospital | Centralia, WA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Providence Health And Services Washington | 7719873496 | 16 |
Providence Health And Services Washington | 9234048323 | 9 |
News Archive
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced that preclinical data from its translational research platform and antibody pipeline will be presented during six poster sessions at the American Association for Cancer Research 101st Annual Meeting 2010 being held April 17-21, 2010, in Washington, D.C.
A Republican filibuster may kill a bill that would extend jobless benefits and extra Medicaid assistance to states while also leaving in limbo efforts to delay cuts in Medicare payments to doctors.
Cancer Research UK scientists have made an important step towards developing personalised bowel cancer treatment by identifying which tumours are more likely to become drug resistant, according to research published in Cancer Research today.
Elderly Medicare black patients have a higher 30-day hospital readmission rate for several conditions including congestive heart failure and pneumonia compared to white patients, that is related in part to higher readmission rates among hospitals that disproportionately care for black patients, according to a study in the February 16 issue of JAMA.
Boston Scientific Corporation today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) and CE Mark approval to market its WallFlex® Fully Covered Esophageal Stent for the treatment of malignant esophageal strictures (obstructions) caused by tumors in patients with resectable or non-resectable esophageal cancer.
› Verified 8 days ago
Entity Name | Providence Health & Services Washington |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1376624981 PECOS PAC ID: 9234048323 Enrollment ID: O20040227000254 |
News Archive
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced that preclinical data from its translational research platform and antibody pipeline will be presented during six poster sessions at the American Association for Cancer Research 101st Annual Meeting 2010 being held April 17-21, 2010, in Washington, D.C.
A Republican filibuster may kill a bill that would extend jobless benefits and extra Medicaid assistance to states while also leaving in limbo efforts to delay cuts in Medicare payments to doctors.
Cancer Research UK scientists have made an important step towards developing personalised bowel cancer treatment by identifying which tumours are more likely to become drug resistant, according to research published in Cancer Research today.
Elderly Medicare black patients have a higher 30-day hospital readmission rate for several conditions including congestive heart failure and pneumonia compared to white patients, that is related in part to higher readmission rates among hospitals that disproportionately care for black patients, according to a study in the February 16 issue of JAMA.
Boston Scientific Corporation today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) and CE Mark approval to market its WallFlex® Fully Covered Esophageal Stent for the treatment of malignant esophageal strictures (obstructions) caused by tumors in patients with resectable or non-resectable esophageal cancer.
› Verified 8 days ago
Entity Name | Providence Health & Services Washington |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1619176997 PECOS PAC ID: 7719873496 Enrollment ID: O20040227000744 |
News Archive
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced that preclinical data from its translational research platform and antibody pipeline will be presented during six poster sessions at the American Association for Cancer Research 101st Annual Meeting 2010 being held April 17-21, 2010, in Washington, D.C.
A Republican filibuster may kill a bill that would extend jobless benefits and extra Medicaid assistance to states while also leaving in limbo efforts to delay cuts in Medicare payments to doctors.
Cancer Research UK scientists have made an important step towards developing personalised bowel cancer treatment by identifying which tumours are more likely to become drug resistant, according to research published in Cancer Research today.
Elderly Medicare black patients have a higher 30-day hospital readmission rate for several conditions including congestive heart failure and pneumonia compared to white patients, that is related in part to higher readmission rates among hospitals that disproportionately care for black patients, according to a study in the February 16 issue of JAMA.
Boston Scientific Corporation today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) and CE Mark approval to market its WallFlex® Fully Covered Esophageal Stent for the treatment of malignant esophageal strictures (obstructions) caused by tumors in patients with resectable or non-resectable esophageal cancer.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Christina R Klein, MD 413 Lilly Rd Ne, Olympia, WA 98506-5133 Ph: (360) 491-9480 | Christina R Klein, MD 413 Lilly Rd Ne, Olympia, WA 98506-5133 Ph: (360) 486-6402 |
News Archive
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced that preclinical data from its translational research platform and antibody pipeline will be presented during six poster sessions at the American Association for Cancer Research 101st Annual Meeting 2010 being held April 17-21, 2010, in Washington, D.C.
A Republican filibuster may kill a bill that would extend jobless benefits and extra Medicaid assistance to states while also leaving in limbo efforts to delay cuts in Medicare payments to doctors.
Cancer Research UK scientists have made an important step towards developing personalised bowel cancer treatment by identifying which tumours are more likely to become drug resistant, according to research published in Cancer Research today.
Elderly Medicare black patients have a higher 30-day hospital readmission rate for several conditions including congestive heart failure and pneumonia compared to white patients, that is related in part to higher readmission rates among hospitals that disproportionately care for black patients, according to a study in the February 16 issue of JAMA.
Boston Scientific Corporation today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) and CE Mark approval to market its WallFlex® Fully Covered Esophageal Stent for the treatment of malignant esophageal strictures (obstructions) caused by tumors in patients with resectable or non-resectable esophageal cancer.
› Verified 8 days ago
Mr. Scott Patrick Shelton, PT, DPT Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 111 Bethel St Ne, Olympia, WA 98506 Phone: 360-596-7532 | |
Dr. Zachary Ian Abbott, DO Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 3901 Capital Mall Dr Sw, Ste A, Olympia, WA 98502 Phone: 360-786-8990 Fax: 360-786-9010 | |
Dr. Edward I. Dagher, MD Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 1822 Black Lake Blvd Sw, Suite 102, Olympia, WA 98512 Phone: 360-877-8862 Fax: 360-878-8619 | |
Thomas W. Hecht, MD Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 410 Providence Ln Ne, Bldg. 2, Olympia, WA 98506 Phone: 360-493-4500 | |
Margo K. Newell-eggert, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 410 Providence Ln Ne, Building 2, Olympia, WA 98506 Phone: 360-493-4500 |